ESE. A. Stabrova

E. A. Stabrova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


E. A. Stabrova has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Е. Ю. Васильева

    Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени В. А. Алмазова» Министерства здравоохранения Российской Федерации

    2 shared publications
  • A. R. Sabirova

    Saint Petersburg State University; Federal State Budgetary Educational Institution of Higher Education “Bashkir State Medical University” of the Ministry of Health of Russia

    1 shared publication
  • Alexey D. Gordeev

    Almazov National Medical Research Center

    1 shared publication
  • Anna Starshinova

    Almazov National Medical Research Centre, St. Petersburg 197341, Russia

    1 shared publication
  • B. B. Musaeva

    Federal State Budgetary Institution “V. A. Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation; Saint Petersburg State University

    1 shared publication
  • Dmitry Anatolievich Kudlay

    Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia

    1 shared publication

Latest Publications

  • Open Access

    Detection of latent tuberculosis infection in individuals before heart transplantation and heart transplant recipients

    by A. R. Sabirova, P. A. Fedotov, R. A. Sharipov, M. A. Simonenko, B. B. Musaeva, E. Yu. Vasilyeva, E. A. Stabrova, I. V. Kudryavtsev, D. A. Kudlay, A. A. Starshinova, et al.

    Background. The effective functioning of the immune system in solid organ recipients against M. tuberculosis may be compromised due to the intensive action of immunosuppressive drugs. Identifying latent tuberculosis infection (LTBI) in patients on the heart transplant waiting list, as well as in heart transplant recipients, may help improve the epidemic situation. Objective. To determent the level of latent tuberculosis infection in patients before and after heart transplantation. Materials and Methods. A comparative prospective cohort study was conducted using immunodiagnostic data from individuals prior to heart transplantation ( n =14) and recipients of a transplanted heart ( n =28). The control group consisted of healthy individuals ( n =69) with no history of contact with TB patients. All participants underwent immunodiagnosis for tuberculosis infection. Results. Positive results were recorded significantly more frequently in recipients of a transplanted heart compared to the control group (53.6 % versus 4.4 %, p =0.001). In the pre-transplant patient group, the level of positive immunodiagnostic results was also significantly higher (35.7 %) than in the control group ( p =0.001). Despite this, there were no statistically significant differences between the recipient group and the transplant candidate group ( p =0.275). Conclusion. The LTBI rate in recipients of a transplanted heart (53.6 %) was determined to be 1.5 times more frequent compared to patients awaiting transplantation (35.7 %). Notably, both comparison groups demonstrated a significantly high level of LTBI relative to healthy individuals (4.4 %), which necessitates further examination of this patient cohort and investigation into the causes of these findings.

  • Open Access

    Molecular circadian markers in acute ischemic stroke (preliminary results)

    by L. S. Korostovtseva, E. N. Zabroda, S. N. Kolomeychuk, A. D. Gordeev, V. V. Amelina, E. A. Stabrova, E. Y. Vasilieva, M. V. Bochkarev, Y. V. Sviryaev, Е. Ю. Васильева

    Background. Ischemic stroke is the leading cause of mortality and loss of working ability. Sleep disorders and sleep-wake rhythm disorders are considered to be a potential modifiable risk factor of acute stroke. Objective. To determine the peculiarities of circadian rhythms in acute stroke by assessing the daily variation of urinary excretion of cortisol and 6-sulfatoxymelatonin. Materials and methods. We examined 27 patients with acute ischemic stroke and 9 patients admitted to the hospital with suspected but not confirmed stroke. All examinations in both groups were performed in similar settings. All patients underwent neurological assessment in acute phase and before discharge including evaluation by National Institute of Health Stroke Scale, modified Rankin scale (mRs), Barthel index and Rivermead index. Within 48–72 hours after admission, urine samples were collected at 7 a. m., 3 p. m. and 11 p. m. for cortisol and 6-sulfatoxymelatonin assessment (enzyme-linked immunosorbent assay analysis). Results. Daily urinary cortisol excretion did not differ in stroke and control subjects. However, stroke patients demonstrated the highest values in the evening while control subjects had higher levels in the morning. The rhythm of urinary 6-sulfatoxymelatonin excretion is preserved in both groups with the highest level in the morning. However, stroke patients show lower levels at all time points (by 45 %, 33 % and 72 % in the morning, afternoon and evening, respectively). There were no changes in either cortisol or 6-sulfatoxymelatonin excretion depending on stroke severity. Afternoon excretion of 6-sulfatoxymelatonin correlates with Barthel index at discharge (ρ = 0,63; p = 0,004), mRs score at discharge (ρ = –0,65; p = 0,003) and Rivermead index at admission (ρ = 0,52; p = 0,024) and at discharge (ρ = 0,49; p = 0,032). Conclusion. Patients with acute mild-moderate stroke show abnormal daily rhythm of urinary cortisol excretion with the maximum in the evening. The daily rhythm of 6-sulfatoxymelatonin excretion is preserved with the maximum excretion at night, but stroke patients have lower levels compared to control subjects.